Clinical Trials
9
Active:2
Completed:2
Trial Phases
1 Phases
Not Applicable:9
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Not Applicable
9 (100.0%)A Randomized Study of Cutting Balloon Catheter for CAD
Not Applicable
Completed
- Conditions
- Coronary Artery DiseasePercutaneous Coronary Intervention (PCI)Calcified Coronary Lesions
- First Posted Date
- 2025-08-26
- Last Posted Date
- 2025-08-26
- Lead Sponsor
- Shanghai Shenqi Medical Technology Co., Ltd
- Target Recruit Count
- 166
- Registration Number
- NCT07140822
- Locations
- 🇨🇳
Meizhou People's Hospital, Meizhou, Guangdong, China
Safety and Effectiveness Study of SQ-Kyrin System for Functional Mitral Regurgitation in EU
Not Applicable
Recruiting
- Conditions
- Functional Mitral Regurgitation
- First Posted Date
- 2025-02-12
- Last Posted Date
- 2025-02-12
- Lead Sponsor
- Shanghai Shenqi Medical Technology Co., Ltd
- Target Recruit Count
- 34
- Registration Number
- NCT06823700
- Locations
- 🇪🇸
Hospital Clínico Universitario de Valladolid, Valladolid, Spain
SQ-Kyrin-T First-in-man Feasibility Study
Not Applicable
Active, not recruiting
- Conditions
- Tricuspid Regurgitation
- First Posted Date
- 2024-09-20
- Last Posted Date
- 2024-09-20
- Lead Sponsor
- Shanghai Shenqi Medical Technology Co., Ltd
- Target Recruit Count
- 12
- Registration Number
- NCT06605313
- Locations
- 🇨🇳
Fuwai Cardiovascular Hospital of Yunnan Province, Kunming, Yunnan, China
Safety and Effectiveness Study of SQ-Kyrin TMVr System for Degenerated Mitral Regurgitation
Not Applicable
- Conditions
- Degenerated Mitral Regurgitation
- First Posted Date
- 2024-06-20
- Last Posted Date
- 2024-06-20
- Lead Sponsor
- Shanghai Shenqi Medical Technology Co., Ltd
- Target Recruit Count
- 118
- Registration Number
- NCT06467110
- Locations
- 🇨🇳
General Hospital of Northern Theater Command, PLA, Shenyang, Liaoning, China
Efficacy and Safety of Intraparenchymal Portal Vein Covered Stents in Treating Portal Hypertension and Its Complications
Not Applicable
Not yet recruiting
- Conditions
- Portal Hypertension
- First Posted Date
- 2024-03-20
- Last Posted Date
- 2024-03-20
- Lead Sponsor
- Shanghai Shenqi Medical Technology Co., Ltd
- Target Recruit Count
- 258
- Registration Number
- NCT06320912
- Locations
- 🇨🇳
Southern Medical University Nanfang Hospital, Guangzhou, Guangdong, China
- Prev
- 1
- 2
- Next
News
No news found